Increased prostaglandin E2 excretion with oral kallikrein treatment in hypertensive and normotensive subjects.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D015232:Dinoprostone; D004231:Diuresis / Q000187:drug effects; D004311:Double-Blind Method; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000652:urine*; D007610:Kallikreins / Q000627:therapeutic use* / Q000652:urine; D009318:Natriuresis / Q000187:drug effects; D011188:Potassium / Q000652:urine; D011458:Prostaglandins E / Q000652:urine*; D013552:Swine
D011458:Prostaglandins E; D007610:Kallikreins; D015232:Dinoprostone; D011188:Potassium